Zilucoplan (Zilbrysq) (AChR-positive gMG) Company: UCB Clinical trial(s): RAISE (Stage 3 complete) More information NICE status: Initial negative guidance after first committee meeting, second committee meeting pending MHRA status: Approved Learn more about Zilucoplan. Manage Cookie Preferences